"The diagnostic value of soluble urokinase plasminogen activator receptor (suPAR) compared to C-reactive protein (CRP) and procalcitonin (PCT) in children with systemic inflammatory response syndrome (SIRS)"
by M Şirinoğlu et al. in Journal of Infection and Chemotherapy, October 2016. Link to abstract here
"SuPAR Predicts Cardiovascular Events and Mortality in Patients With Asymptomatic Aortic Stenosis"
by GW Hodges et al. in Canadian Journal of Cardiology, May 2016. Link to abstract here
"Soluble urokinase plasminogen activation receptor - An emerging new biomarker of cardiovascular disease and critical illness"
by NB Cyrille et al. in Annals of Cardiac Anaesthesia, June 2016. Link to abstract here
suPAR data have been presented at several conferences.
One of the more interesting findings were that "suPAR predicts cardiovascular outcomes in heart failure independently of high sensitivity Troponin I"
by Salim S Hayek et al. in Circulation, 2016. Link to abstract here